ArticleBMJ open2025

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Kelvin Kar-Wing Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.